New

Vetoryl Capsules

Vetoryl capsules contain the drug trilostane which has demonstrated to be effective in the treatment of Cushings syndrome in dogs. Vetoryl will be indicated for use in pituitary-dependent hyperadrenocorticism which comprises the majority of cases of Cushing's syndrome in dogs. Also Vetoryl has received designation status as a Minor Use drug treatment of hyperadrenocorticism caused by adrenal tumors - the first drug to receive an approval for this indication and the first drug to receive a Minor Drug Use designation in dogs.



Complementary Content
${loading}